The use of OKT3 in combined pancreas-kidney allotransplantation.
Melzer
J S
JS
University of Wisconsin School of Medicine, Madison.
D'Alessandro
A M
AM
Kalayoglu
M
M
Pirsch
J D
JD
Belzer
F O
FO
Sollinger
H W
HW
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D003928:Diabetic Nephropathies / Q000601:surgery; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D016035:Pancreas Transplantation / Q000276:immunology*; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum